Sanofi (SNY) Minority Interest (2010 - 2025)

Sanofi has disclosed Minority Interest across 16 years of filings, most recently posting $570.4 million for Q4 2025.

• Minority Interest for Q4 2025 came in at $570.4 million, up 52.5% year-over-year; the trailing twelve-month figure through Dec 2025 was $570.4 million (up 52.5% YoY), and the FY2025 annual result was $570.4 million, up 52.5% from the prior year.
• Minority Interest came in at $570.4 million for Q4 2025 at Sanofi, up from $306.8 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $570.4 million in Q4 2025 to a low of $18.3 million in Q2 2024.
• The 5-year median for Minority Interest is $321.8 million (2023), against an average of $249.1 million.
• Across the five-year window, Minority Interest sank 49.94% in 2023 and surged 1575.64% in 2025, its largest moves.
• Sanofi's Minority Interest stood at $400.4 million in 2021, then slipped by 6.23% to $375.5 million in 2022, then dropped by 10.3% to $336.8 million in 2023, then climbed by 11.06% to $374.0 million in 2024, then soared by 52.5% to $570.4 million in 2025.
• The last three Minority Interest figures came in at $570.4 million (Q4 2025), $306.8 million (Q2 2025), and $374.0 million (Q4 2024), per Business Quant data.